Voyager Therapeutics (VYGR) Current Assets (2014 - 2026)

Voyager Therapeutics has disclosed Current Assets across 13 years of filings, most recently posting $125.2 million for Q2 2026.

• In Q2 2026, Current Assets fell 45.05% year-over-year to $125.2 million; the TTM figure through Jun 2026 stood at $125.2 million (down 45.05% YoY), while the FY2025 annual figure was $202.7 million, down 26.78% from the prior year.
• Current Assets came in at $125.2 million for Q2 2026 at Voyager Therapeutics, down from $147.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $409.1 million in Q1 2024 to a low of $124.5 million in Q4 2022.
• Average Current Assets over 5 years is $242.7 million, with a median of $236.5 million recorded in 2025.
• Year-over-year, Current Assets jumped 156.78% in 2023 and tumbled 45.05% in 2026.
• Over 5 years, Current Assets stood at $124.5 million in 2022, then surged by 156.78% to $319.7 million in 2023, then dropped by 13.41% to $276.8 million in 2024, then slipped by 26.78% to $202.7 million in 2025, then sank by 38.22% to $125.2 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $125.2 million in Q2 2026, $147.0 million in Q1 2026, and $202.7 million in Q4 2025.